ArticleClinics (Sao Paulo, Brazil)2026

Validation of the GALAD model for diagnosing HBV-related hepatocellular carcinoma in Chinese patients.

KeCheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.